Lack of association between tumor oxygenation and cell cycle distribution or proliferation kinetics in experimental sarcomas

Advances in Experimental Medicine and Biology

Volumn 540, Issue , 2003, Pages 245-250

  Thews, Oliver ^b   Kelleher, Debra K ^b   Vaupel, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENT; GROWTH RATE; HYPOXIA; IN VIVO STUDY; KINETICS; MALE; MEASUREMENT; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RAT; SARCOMA; SOLID TUMOR; TUMOR GROWTH;

ANIMALIA;

EID: 0842265751     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-6125-2_34     Document Type: Conference Paper

References (17)

1. T.Fujii, T.Otsuki, T.Moriya, H.Sakaguchi, J.Kurebayashi, K.Yata, M.Uno, T.Kobayashi, T.Kimura, Y.Jo, K.Kinugawa, Y.Furukawa, M.Morioka, A.Ueki, and H.Tanaka, Effect of hypoxia on human seminoma cells, Int.J.Oncol. 20, 955-962 (2002).
2. A.Krtolica, N.A.Krucher, and J.W.Ludlow, Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells, Br.J.Cancer 80, 1875-1883 (1999).
3. Y.Ogiso, A.Tomida, H.D.Kim, and T.Tsuruo, Glucose starvation and hypoxia induce nuclear accumulation of proteasome in cancer cells, Biochem.Biophys.Res. Commun. 258, 448-452 (1999).
4. M.Höckel, K.Schlenger, B.Aral, M.Mitze, U.Schäffer, and P.Vaupel, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix, Cancer Res. 56, 4509-4515 (1996).
5. M.Höckel and P.Vaupel, Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects, J.Natl.Cancer Inst. 93, 266-276 (2001).
6. C.D.Coleman, Clinical Applications of Molecular Biology in Radiation Oncology, Semin.Radiat.Oncol. 6, 245-249 (1996).
7. E.J.Hall, Radiobiology for the Radiologist, 5 Ed. (J.B. Lippincott, Philadelphia, 2000).
8. M.Kartalou and J.M.Essigmann, Mechanisms of resistance to cisplatin, Mutat.Res. 478, 23-43 (2001).
9. C.K.Luk, L.Veinot-Drebot, E.Tjan, and I.F.Tannock, Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines, J.Natl.Cancer Inst. 82, 684-692 (1990).
10. D.Murray and R.E.Meyn, Cell cycle-dependent cytotoxicity of alkylating agents: determination of nitrogen mustard-induced DNA cross-links and their repair in Chinese hamster ovary cells synchronized by centrifugal elutriation, Cancer Res. 46, 2324-2329 (1986).
11. E.K.Rowinsky, M.J.Citardi, D.A.Noe, and R.C.Donehower, Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine, J.Cancer Res.Clin.Oncol. 119, 727-733 (1993).
12. A.Tomida and T.Tsuruo, Drug resistance mediated by cellular stress response to the microenvironment of solid tumors, Anticancer Drug Des 14, 169-177 (1999).
13. A.A.van de Loosdrecht, G.J.Ossenkoppele, R.H.Beelen, M.G.Broekhoven, and M.M.Langenhuijsen, Cell cycle specific effects of tumor necrosis factor alpha in monocyte mediated leukemic cell death and the role of beta 2-integrins, Cancer Res. 53, 4399-4407 (1993).
14. O.Amellem and E.O.Pettersen, Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage, Cell Prolif. 24, 127-141 (1991).
15. D.J.Chaplin, P.L.Olive, and R.E.Durand, Intermittent blood flow in a murine tumor: radiobiological effects, Cancer Res. 47, 597-601 (1987).
16. A.S.Kennedy, J.A.Raleigh, G.M.Perez, D.P.Calkins, D.E.Thrall, D.B.Novotny, and M.A.Varia, Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays, Int.J.Radiat.Oncol.Biol.Phys. 37, 897-905 (1997).
17. M.Nordsmark, M.Hoyer, J.Keller, O.S.Nielsen, O.M.Jensen, and J.Overgaard, The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas, Int.J.Radiat.Oncol.Biol.Phys. 35, 701-708 (1996).